Home › Studies › PRJNA400628
PRJNA400628 SRP117119

Gut E. coli in recurrent UTI case-control study, St. Louis

Escherichia coli Genome sequencing and assembly

422 stool samples from women in St. Louis, MO, USA, comparing gut E. coli (via E. coli PanSelect enrichment) between recurrent UTI cases and healthy controls, in a case-control design. machine-written summary

422 samples · 721 runs · US · Age unknown · 2017 · 3.76 Gbp / sample

Sources
✓Sequence archive 2,160✓Abstract / description 232✓Full text 422✓Supplementary tables 292–External resources–User contribution–Human verified

Checked this project's papers and archive records yourself? Mark it human-verified.

what each source gave
✓ Sequence archive2,160 sample values (collection date, country, location locality, location region, subject id, timepoint)
✓ Abstract / description232 sample values (health condition detail)
✓ Full text422 sample values (sex) · PMC11133793, PMC11530686, PMC12122369, PMC8900328, PMC9136705
✓ Supplementary tables292 sample values (health condition, health condition detail, timepoint)
– External resourcesnot covered by the external resources we ingest
– User contributionnothing uploaded yet · share metadata
– Human verifiednot yet checked by a person · I checked this project — verify it
Samples at a glance
1 country
Age
unknown422
Condition
healthy_control97
Sex
female422
Country
US422
Body site
primary422
Collected 2015–2017
2015: 39 samples2016: 223 samples2017: 36 samples20152017
Sequencing depth per sample · this project all projects
all projects, 0–0.03 Gbp: 25,080 samples (4 %)this project, 0–0.03 Gbp: 3 samplesall projects, 0.03–0.1 Gbp: 17,066 samples (3 %)this project, 0.03–0.1 Gbp: 2 samplesall projects, 0.1–0.3 Gbp: 29,179 samples (5 %)this project, 0.1–0.3 Gbp: 1 samplesall projects, 0.3–1 Gbp: 47,044 samples (8 %)this project, 0.3–1 Gbp: 4 samplesall projects, 1–3 Gbp: 124,983 samples (22 %)this project, 1–3 Gbp: 96 samplesall projects, 3–10 Gbp: 253,728 samples (44 %)this project, 3–10 Gbp: 296 samplesall projects, 10–30 Gbp: 72,533 samples (13 %)this project, 10–30 Gbp: 16 samplesall projects, 30–100 Gbp: 3,024 samples (1 %)this project, 30–100 Gbp: 4 samplesall projects, 100–300 Gbp: 106 samples (0 %)all projects, ≥ 300 Gbp: 9 samples (0 %)project median 4.23 Gbp per sample0130Gbp
Sampling design and relatedness

longitudinal

31 of 31 people sampled more than once (422 samples; median 13, up to 24 per person) · follow-up median 23 d (max 12 mo) · median interval between samples 36 d (time from collection dates). Schedule stated by the source: “year-long longitudinal stool sampling of women with recurrent UTI, numbered timepoints per subject (e.g. UMB05_04, UMB05_05, UMB05_06)” (time origin: enrolment); stated follow-up 12 mo.

UMB06UMB06: day 0UMB06: day 15UMB06: day 51UMB06: day 87UMB06: day 142UMB06: day 198UMB06: day 234UMB06: day 280UMB06: day 295UMB06: day 331UMB06: day 359UMB14UMB14: day 0UMB14: day 23UMB30UMB30: day 0UMB30: day 170 d3 mo6 mo9 mo12 mo

Each row is one person (3 shown of 31); dots are samples at days since that person's first sample.

How longitudinal and relatedness information is derived

Community composition
Bacteroides 24.1%Phocaeicola 12.8%Escherichia 10.8%Alistipes 9.4%Faecalibacterium 5.4%Parabacteroides 2.4%Roseburia 2.3%Prevotella 2.1%Akkermansia 1.9%Ruminiclostridium_E 0.9%Hominicoprocola 0.8%Oscillibacter 0.8%not assigned to a genus 8.0%other genera 18.4%

Genera, mean relative abundance over 387 profiled gut samples of this project (Sandpiper SingleM profiles, GTDB R232; low-depth and non-metagenome profiles left out).

Field coverage
fieldsamplescoverageR1R2R3R4
age_category0 0%
country422 100%422
health_condition97 23%97
subject_id422 100%422
detailed_location422 100%
health_condition_detail422 100%190232
location_locality422 100%422
location_region422 100%422
sex422 100%422
collection_date298 71%298
timepoint_label179 42%1745
Papers (5)
  • StrainGE: a toolkit to track and characterize low-abundance strains in complex microbial communities. 2022 PMID 35255937 PMC8900328 own_data
  • Longitudinal multi-omics analyses link gut microbiome dysbiosis with recurrent urinary tract infections in women. 2022 PMID 35505248 PMC9136705 own_data
  • Distinct Escherichia coli transcriptional profiles in the guts of recurrent UTI sufferers revealed by pangenome hybrid selection. 2024 PMID 39487120 PMC11530686 own_data
  • Longitudinal profiling of low-abundance strains in microbiomes with ChronoStrain. 2025 PMID 40328944 PMC12122369 own_data
  • Gut microbiome correlates of recurrent urinary tract infection: a longitudinal, multi-center study. 2024 PMID 38813445 PMC11133793 unsure
Details
Archive description

Metagenomic samples extracted from Stool of UI cases/control patients and 16S sequenced

How this project entered the registry

Classified as human gut / stool / vaginal / urogenital shotgun DNA metagenome of age unknown by sonnet_x2 with confidence 0.53. Assay shotgun_dna.

  • host study.description · “Stool of UI cases/control patients”
  • body site study.description · “Stool of UI cases/control patients”
  • body site sample.attr.isolation_source · “urine (n=93/515)”
Evidence examples (one per field × route)
samplefieldvaluerouteconf.sourcequote
SAMN07583764collection_date2015-10-26R10.90biosample.attribute:collection_date2015-10-26
SAMN07583764countryUSR10.90sample.attr.geo_loc_nameUSA:MO,St.Louis
SAMN07583764health_conditionhealthy_controlR20.80paper.supp.41467_2024_53829_MOESM3_ESM.xlsx[Sheet1!cohort]healthy
SAMN07583764health_condition_detailhealthyR20.85paper.supp.41467_2024_53829_MOESM3_ESM.xlsx[Sheet1!cohort]healthy
SAMN07583766health_condition_detailmixed_case_control: recurrent urinary tract infection cases vs controlsR40.40paper.abstractwomen with and without history of rUTI
SAMN07583764location_localitySt. LouisR10.75biosample.attribute:geo_loc_nameUSA:MO,St.Louis
SAMN07583764location_regionMissouriR10.75biosample.attribute:geo_loc_nameUSA:MO,St.Louis
SAMN07583764sexfemaleR30.70paper.fulltext.methodsThis study recruited only women
SAMN07583764subject_idUMB01R10.70sample.name_rule:aliasUMB01_00
SAMN07583764timepoint_label00R10.70sample.name_rule:aliasUMB01_00
SAMN07583894timepoint_label2R20.85paper.supp.13059_2022_2630_MOESM3_ESM.xlsx[UTI sample identifiers!Time point]2
Sequencing

721 runs over 422 samples · mean 3.18 Gbp per run (median 2.89 Gbp, total 2,292.34 Gbp; 721 runs with a base count) · layout PAIRED 713, SINGLE 8 · platform ILLUMINA 713, OXFORD_NANOPORE 8 · models HiSeq X Ten (390), Illumina NovaSeq 6000 (222), Illumina HiSeq 2500 (101), GridION (8) · 80% of runs with a Sandpiper profile · first public 2017-11-09 – 2024-06-15

Authors (70)

van Dijk LR first · Walker BJ · Straub TJ · Worby CJ · Grote A · Schreiber HL · Anyansi C · Pickering AJ · Hultgren SJ · Manson AL · Abeel T · Earl AM last · Bronson RA · Olson BS · Pinkner JS · Obernuefemann CLP · Muñoz VL · Paharik AE · Azimzadeh PN · Desjardins CA · Chou WC · Bergeron K · Chapman SB · Klim A · Hannan TJ · Hooton TM · Kau AL · Lai HH · Dodson KW · Choi J first · Thänert R · Reske KA · Nickel KB · Olsen MA · Hink T · Thänert A · Wallace MA · Wang B · Cass C · Barlet MH · Struttmann EL · Iqbal ZH · Sax SR · Fraser VJ · Baker AW · Foy KR · Williams B · Xu B · Capocci-Tolomeo P · Lautenbach E · Burnham CD · Dubberke ER · Dantas G · Kwon JH · CDC Prevention Epicenters Program last · Young MG first · Metsky HC · Gnirke A · Matranga C · Qu J · Villicana JB · Azimzadeh P · Kau A · Kim Y first · Acharya S · Alfonsetti D · Gromko Z · Gerber GK · Berger B · Gibson TE last

Help complete this project

2 of the 4 core fields are below 50% coverage: age_category, health_condition. Share metadata

Downloads

PRJNA400628.csv.gz (12.3 KB) · parquet (85.9 KB) — all 422 samples, every field with route and confidence · PRJNA400628_determinations.csv.gz (22.0 KB) — 3,106 evidence rows

Samples (422 · every field this project has values for · hover a cell for its source)
Loading the sample table…